Quick Answer
Bluejay Diagnostics, Inc. reported Net Income of -$6.85 million for fiscal year 2025.
Bluejay Diagnostics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$6.85M | +11.3% |
| 2024 | -$7.72M | +22.5% |
| 2023 | -$9.95M | -7.1% |
| 2022 | -$9.30M | -166.5% |
| 2021 | -$3.49M | -201.2% |
| 2020 | -$1.16M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.60M | -7.8% | +18.3% |
| June 30, 2025 | -$1.96M | +21.0% | -4.9% |
| March 31, 2025 | -$1.86M | +19.9% | -25.8% |
| September 30, 2024 | -$1.48M | +35.5% | +40.1% |
| June 30, 2024 | -$2.48M | +12.0% | -6.3% |
| March 31, 2024 | -$2.33M | +8.3% | -1.3% |
| September 30, 2023 | -$2.30M | +22.4% | +18.3% |
| June 30, 2023 | -$2.81M | -45.2% | -10.8% |
- Bluejay Diagnostics, Inc. showed an increase of +11.3% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Bluejay Diagnostics, Inc.’s net income has declined by 491.3% (from -$1.16 million to -$6.85 million).
- The most recent figure is from Bluejay Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: